The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use
Nucleic Acids Res. 2023 Jan 6;51(D1):D1492-D1502. doi: 10.1093/nar/gkac909.ABSTRACTWe…
The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis
PLoS Negl Trop Dis. 2022 Oct 19;16(10):e0010807. doi: 10.1371/journal.pntd.0010807.…
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma
Hematol Oncol. 2023 Feb;41(1):108-119. doi: 10.1002/hon.3089.…
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
Nat Med. 2022 Nov;28(11):2364-2373. doi: 10.1038/s41591-022-02015-7.…
Optimization of a GC-MS Injection-Port Derivatization Methodology to Enhance Metabolomics Analysis Throughput in Biological Samples
J Proteome Res. 2022 Nov 4;21(11):2555-2565. doi: 10.1021/acs.jproteome.2c00119.…
Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper
Lancet Haematol. 2022 Oct;9(10):e786-e795. doi: 10.1016/S2352-3026(22)00226-5.ABSTRACTChimeric…
Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer
Cancer Discov. 2022 Dec 2;12(12):2930-2953. doi: 10.1158/2159-8290.CD-21-0865.ABSTRACTSystematically…
Nutritional Niches of Cancer Therapy-Induced Senescent Cells
Nutrients. 2022 Sep 2;14(17):3636. doi: 10.3390/nu14173636.ABSTRACTTherapy-induced…
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells
Int J Mol Sci. 2022 Sep 1;23(17):9986. doi: 10.3390/ijms23179986.ABSTRACTThe…
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study
Eur Urol. 2023 Jan;83(1):15-26. doi: 10.1016/j.eururo.2022.08.005.…
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era
Front Immunol. 2022 Aug 8;13:1002615. doi: 10.3389/fimmu.2022.1002615.…
Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
Cell Death Dis. 2022 Aug 24;13(8):730. doi: 10.1038/s41419-022-05177-x.ABSTRACTOn…
